Impaired sulphated glycosaminoglycan metabolism in a patient with GM-2 gangliosidosis (Tay-Sachs disease)
- 33 Downloads
- 3 Citations
Summary
An abnormal urinary excretion of sulphated glycosaminoglycans in a patient with GM-2 gangliosidosis (Tay-Sachs disease) is described. Besides the accumulation of GM-2 ganglioside in liver and lack of hexosaminidase A, the patient shows an abnormal urinary excretion of an iduronic acid-rich low molecular weight heparan sulphate. Also, no dermatan sulphate could be detected in the urine, whereas this compound was the main sulphated glycosaminoglycan in the liver of the patient. Heparan sulphate was the main glycosaminoglycan of normal liver. The total amount of sulphated glycosaminoglycans in the urine and liver of the patient did not differ significantly from the amounts found in the liver and urine of normal subjects. Several plasma glycosidases have been assayed and the activities did not differ significantly from the values obtained for the plasma of normal subjects.
Keywords
Public Health Sulphated Molecular Weight Internal Medicine Metabolic DiseasePreview
Unable to display preview. Download preview PDF.
References
- Bianchini, P., Nader, H. B., Takahashi, H. K., Osima, B., Straus, A. H. and Dietrich, C. P. Fractionation and identification of heparin and other acidic mucopolysaccharides by a new discontinuous electrophoretic method.J. Chromatog. 196 (1980) 455–462Google Scholar
- Cassaro, C. M. F. and Dietrich, C. P. Distribution of sulfated mucopolysaccharides in invertebrates.J. Biol. Chem. 252 (1977) 2254–2261Google Scholar
- Dietrich, C. P., Mourão, P. A. S. and Toledo, S. P. A. A new mucopolysaccharidosis characterized by excretion of chondroitin sulfate C of low sulfate content. In Piras, R. and Pontis, G. H. (eds.),Biochemistry of the Glycosidic Linkage, Academic Press, New York, 1972, pp. 751–758Google Scholar
- Dietrich, C. P. and Nader, H. B. Fractionation and properties of four heparitin sulfates from beef lung tissue. Isolation and partial characterization of a homogenous species of heparitin sulfate.Biochim. Biophys. Acta 343 (1974) 34–44Google Scholar
- DiFerrante, N., Nichols, B. L., Donnelly, P. V., Neri, G., Argovic, R. and Berglund, R. K. Induced degradation of glycosaminoglycans in Hurlers and Hunters syndromes by plasma infusion.Proc. Natl. Acad. Sci. USA 68 (1971) 303–307Google Scholar
- Hall, C. W. and Neufeld, E. F.L-Iduronidase activity in cultured skin fibroblasts and amniotic fluid cells.Arch. Biochem. Biophys. 158 (1973) 817–821Google Scholar
- Ikeno, T., Minami, R., Tsugawa, S. K. and Nakao, T. Acidic glycosaminoglycans and gangliosides in the brain from four patients with genetic mucopolysaccharidosis.Tohoku J. Exp. Med. 137 (1982) 253–260Google Scholar
- Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. Protein measurement with the folin phenol reagent.J. Biol. Chem. 193 (1951) 265–275Google Scholar
- McKusick, V. A. The nosology of the mucopolysaccharidoses.Am. J. Med. (1969) 730–747Google Scholar
- Meyer, K., Grumbak, M. M., Linker, A. and Hoffman, P. Excretion of sulfated mucopolysaccharides in Gargoylism (Hurlers syndrome).Proc. Soc. Exp. Biol. Med. 97 (1958) 275–279Google Scholar
- Mourão, P. A. S., Toledo, S. P. A., Nader, H. B. and Dietrich, C. P. Excretion of chondroitin sulfate C with low sulfate content by patients with generalized platyspondily (brachyolmia).Biochem. Med. 7 (1973) 415–423Google Scholar
- Mourão, P. A. S., Kato, S. and Donelly, P. V. Spondyloepiphyseal dysplasia, chondroitin sulfate type: a possible defect of PAPS-chondroitin sulfate sulfotransferase in humans.Biochem. Biophys. Res. Commun. 98 (1981) 388–396Google Scholar
- Nader, H. B., Cohen, D. M. and Dietrich, C. P. Chemistry of heparitin sulfate and heparin from normal tissues and from patients with Hunter syndromeBiochim. Biophys. Acta 582 (1979) 33–43Google Scholar
- Nader, H. B., Dietrich, C. P., Buonassisi, V. and Colburn, P. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan.Proc. Natl. Acad. Sci. USA 84 (1987) 3565–3569Google Scholar
- Neufeld, E. F. The biochemical basis for mucopolysaccharidoses and mucolipidoses. In Steinberg, A. G. and Bearn, A. C. (eds.),Progress in Medical Genetics 10 (1974) 81–101Google Scholar
- O'Brien, J. S., Odara, S., Chen, A. and Fillerup, B. S. Tay-Sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay.N. Engl. J. Med. 283 (1970) 15–20Google Scholar
- Toledo, S. P. A., Mourão, P. A. S., Lamego, C., Alves, C. A., Dietrich, C.P., Assis, L. M. and Mattar, E. Recessively inherited, late onset, spondylar dysplasia and peripheral corneal opacity with anomalies in the urinary mucopolysaccharides. A possible error of chondroitin sulfate synthesis.Am. J. Med. Genet. 2 (1978) 385–395Google Scholar
- Van Hoof, F., Mucopolysaccharidoses. In Hers, H. G. and Van Hoof, F. (eds.),Lysosomes and Storage Diseases, Academic Press, New York, 1973, 217–259Google Scholar